In his weekly clinical update, Dr. Griffin discusses the potential for recurrent Mpox outbreaks among gay, bisexual, and other men who have sex with men, association between SARS-CoV-2 variants and frequency of acute symptoms, prospective study of key correlates for household transmission of SARS-CoV-2, Pfizer’s PAXLOVID
receiving FDA approval for adult patients at high risk of progression to severe COVID-19, efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19, development of a definition of postacute sequelae of SARS-CoV-2 infection, COVID-19 and risk for mental disorders among adults in Denmark, risk of new post-COVID mental disorders higher only in older patients.
Click arrow to play
Download TWiV 1012 (23 MB .mp3, 38 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Potential for recurrent Mpox outbreaks among men who have sex with men (CDC) 3:31
- Association between SARS-CoV-2 variants and frequency of acute symptoms (OFID) 8:19
- Key correlates for household transmission of SARS-CoV-2 (OFID) 10:54
- PAXLOVID receiving FDA approval for patients at high risk of severe COVID-19 (Pfizer) 12:35
- Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients with COVID-19 (The Lancet) 14:44
- Development of a definition of postacute sequelae of SARS-CoV-2 (JAMA) 17:46
- COVID-19 and risk for mental disorders among adults in Denmark (JAMA) 25:40
- Risk of new post-COVID mental disorders higher only in older patients (CIDRAP) 25:50
- Contribute to our FIMRC fundraiser at PWB 29:21
- Letters read on TWiV 1012 29:54
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
The post TWiV 1012: Clinical update with Dr. Daniel Griffin first appeared on This Week in Virology.